A Study to Explore Pharmacokinetics/Pharmacodynamics and Safety of Tegoprazan BID Dosing in Healthy Subjects

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

June 30, 2021

Conditions

Healthy

Interventions

DRUG

Tegoprazan dose A or placebo

Tegoprazan A mg or placebo taken orally twice daily for 3 days.

DRUG

Tegoprazan dose B or placebo

Tegoprazan B mg or placebo taken orally twice daily for 3 days.

DRUG

Tegoprazan dose C or placebo

Tegoprazan C mg or placebo taken orally twice daily for 3 days.

DRUG

Tegoprazan dose D or placebo

Tegoprazan D mg or placebo taken orally twice daily for 3 days.

Trial Locations (1)

RECRUITING

Inje University Busan Paik Hospital, Busan